Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Learn the basics of currency risk in international funds and how it can affect diversification and overall performance.
26,930 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
With summer on the horizon, energy markets react to travel demand and geopolitics. This guide highlights three energy...
As IPO chatter heats up in 2026, SpaceX faces a pivotal moment. The CFO’s quiet leadership could define the deal, unl...
A Live Oak Bancshares CEO sold 20,000 shares for roughly $769,000 in mid-June. Is this a warning sign or routine dive...
Investors weigh AI infrastructure costs against Azure growth as Microsoft and tech peers face margin pressure. Here’s...
AI is driving big changes in how we file taxes and how policies are written. This article breaks down what to expect,...
Oracle shares hover near $144 as AI infrastructure demand meets cash-flow headwinds. A rising backlog and lofty reven...
June brought a tighter landscape for mortgage credit as government-backed programs pulled back, pushing the MBA’s MCA...
Trump Media plans a rapid data feed of Truth Social posts for market participants, a move that could reshape timing i...
Headline drama can ripple through your finances. Learn practical steps to stay focused, protect your investments, and...
A high-profile stance can carry a price in Hollywood. This article explains the financial lessons from Susan Sarandon...
PI token rockets after a major exchange adds trading, even as Bitcoin stalls below $70,000. Analysts say new liquidit...